Skip to main content
Download PDF

Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

Breast Cancer Research volume 26, Article number: 58 (2024) Cite this article

The Original Article was published on 26 February 2016

Correction: Breast Cancer Research (2016) 18:26 https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13058-016-0686-4

Following the publication of the original article [1], the author reported that PARP blots of JIMT-1 and JIMT-1-BR3 cells in Fig. 7C of the original publication were mistakenly duplicated.

Error image

figure a

The correct figure below depicts the correct PARP blot for JIMT-1 cells.

Correct image

figure b

The error does not affect any of the interpretations or conclusions of the article.

The email address of the Corresponding Author has also been updated, from klaus.podar@nct-heidelberg.de to klaus.podar@krems.lknoe.at as shown in this Correction article.

The original article [1] has been updated.

Reference

  1. Bashari MH, Fan F, Vallet S, et al. Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications. Breast Cancer Res. 2016;18:26. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13058-016-0686-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Im Neuenheimer Feld #460, 69120, Heidelberg, Germany

    Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet, Claudia Luckner-Minden, Henning Schulze-Bergkamen, Inka Zörnig, Frederik Marme, Andreas Schneeweiss, Dirk Jäger & Klaus Podar

  2. Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Padjadjaran, Jl. Eijkman 38, Bandung, 02215, Indonesia

    Muhammad Hasan Bashari

  3. Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA

    Martin Sattler

  4. Eutropics, Inc., 767C Concord Avenue, Cambridge, MA, 02138, USA

    Melissa Arn & Michael H. Cardone

  5. German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany

    Claudia Luckner-Minden, Inka Zörnig & Dirk Jäger

  6. St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA

    Joseph T. Opferman

Authors
  1. Muhammad Hasan Bashari
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Fengjuan Fan
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Sonia Vallet
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Martin Sattler
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Melissa Arn
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Claudia Luckner-Minden
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Henning Schulze-Bergkamen
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. Inka Zörnig
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. Frederik Marme
    View author publications

    You can also search for this author inPubMed Google Scholar

  10. Andreas Schneeweiss
    View author publications

    You can also search for this author inPubMed Google Scholar

  11. Michael H. Cardone
    View author publications

    You can also search for this author inPubMed Google Scholar

  12. Joseph T. Opferman
    View author publications

    You can also search for this author inPubMed Google Scholar

  13. Dirk Jäger
    View author publications

    You can also search for this author inPubMed Google Scholar

  14. Klaus Podar
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Klaus Podar.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bashari, M.H., Fan, F., Vallet, S. et al. Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications. Breast Cancer Res 26, 58 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13058-024-01811-y

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13058-024-01811-y

Breast Cancer Research

ISSN: 1465-542X

Contact us